Primary Antibodies

View as table Download

LCMT1 mouse monoclonal antibody, clone OTI2C9 (formerly 2C9)

Applications IHC, WB
Reactivities Human, Rat, Monkey, Mouse
Conjugation Unconjugated

ALDH1A3 mouse monoclonal antibody, clone OTI4B6 (formerly 4B6)

Applications FC, IHC, WB
Reactivities Human, Dog, Monkey, Mouse, Rat
Conjugation Unconjugated

ACY3 mouse monoclonal antibody, clone OTI2D5 (formerly 2D5)

Applications FC, IF, IHC, WB
Reactivities Human, Monkey
Conjugation Unconjugated

ACY3 mouse monoclonal antibody,, clone OTI4H7 (formerly 4H7)

Applications FC, IHC, WB
Reactivities Human, Dog, Monkey
Conjugation Unconjugated

FTCD mouse monoclonal antibody, clone OTI7C5 (formerly 7C5)

Applications FC, WB
Reactivities Human, Monkey
Conjugation Unconjugated

LCMT1 mouse monoclonal antibody, clone OTI2C9 (formerly 2C9)

Applications IHC, WB
Reactivities Human, Rat, Monkey, Mouse
Conjugation Unconjugated

FTCD mouse monoclonal antibody, clone OTI4B6 (formerly 4B6)

Applications WB
Reactivities Human, Mouse, Monkey
Conjugation Unconjugated

ALDH1A3 mouse monoclonal antibody, clone OTI4B6 (formerly 4B6)

Applications FC, IHC, WB
Reactivities Human, Dog, Monkey, Mouse, Rat
Conjugation Unconjugated

Goat Polyclonal Anti-FTCD Antibody

Applications IF, WB
Reactivities Canine, Human, Monkey, Mouse, Rat
Conjugation Unconjugated
Immunogen Purified recombinant peptide derived from within residues 50 aa to the N-terminus of human FTCD produced in E. coli.

Monoamine Oxidase B / MAOB Goat Polyclonal (Internal) Antibody

Applications IHC
Reactivities Bovine, Gorilla, Human, Monkey, Pig, Rabbit, Gibbon, Horse, Orang-Utan, Guinea Pig (Predicted: Mouse, Rat, Dog)
Conjugation Unconjugated
Immunogen MAOB / Monoamine Oxidase B antibody was raised against synthetic peptide C-HKARKLARLTKEE from an internal region of human MAOB (NP_000889.3). Percent identity by BLAST analysis: Human, Gorilla, Orangutan, Gibbon, Monkey, Marmoset, Elephant, Bovine, Rabbit, Horse, Pig, Opossum, Guinea pig (100%); Mouse, Rat, Panda, Dog (92%); Bat (85%).